Venture Capital

A new business coalition forms to protect NYC's Israeli tech sector, citing hostile policy shifts and rising antisemitism that threaten a vital economic engine.

A former Navy SEAL's tech startup marks one year of using AI to help veterans navigate the VA claims maze for free, taking on predatory firms and red tape.

A new partnership between Southern Research and Pathogenus Consulting combines US labs with a European network to fast-track treatments for global health threats.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

As AI’s energy crisis looms, Oxford spinout Lumai appoints a tech giant to bring its power-saving optical computing from the lab to the data center.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

With $105M in funding and stunning client results, Eudia's 'Augmented Intelligence' is transforming corporate legal from a cost center to a powerhouse.

With an $80M backlog and a new 'Buy' rating, cybersecurity firm Cycurion looks poised for growth. But can it overcome its volatile past and prove its worth?

Precision medicine firm Atropos Health joins NY's elite digital health startups, signaling a market shift toward scalable, data-driven healthcare solutions.

As millions face losing healthcare, AI startup Graici has secured $7.5M to automate Medicaid renewals, betting its data wallet can solve a national crisis.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

With a new veteran advisor, SpinLaunch pivots to commercialize its Meridian LEO network, aiming for a 'sovereign' niche in the competitive satellite market.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

Tractor Beverage's Haymaker line earns a stringent purity certification, signaling a major retail pivot where 'organic' is no longer the final word.

The 'better-for-you' brand is making a massive retail play, adding new executives and launching innovative gummies to capture the $100B energy market.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

A new report reveals AI-powered disinformation is bypassing firewalls, costing billions. Experts say firms are dangerously unprepared for this new reality.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

A legacy manufacturer turned decades of dormant engineering files into a strategic asset, recovering 600 hours and boosting efficiency by 98% with AI.